UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 8-K

_____________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 27, 2014

LDR HOLDING CORPORATION

(Exact Name of Registrant as Specified in its Charter)

_____________________

Delaware (State or Other Jurisdiction of Incorporation)	001-36095 (Commission File Number)	20-3933262 (I.R.S. Employer Identification No.)
13785 Research Boulevard, Suite 200 Austin, Texas (Address of Principal Executive Offices)		78750 (Zip Code)
Registrant’s telephone number including area code: (512) 344-3333
No change since last report (Former Name or Address, if Changed Since Last Report)

_____________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 1 - Registrant's Business and Operations

Item 1.01Entry into a Material Definitive Agreement.

On August 27, 2014, LDR Médical, S.A.S. (“LDR Médical”), a wholly owned subsidiary of LDR Holding Corporation (the “Company”), entered into an amendment (the “Amendment”) with Invibio Ltd. to the Supply Agreement, dated January 31, 2003, as amended, to extend the term of such agreement through October 1, 2014.

The foregoing description of the Amendment does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

Exhibit Number	Description
10.1	Amendment, dated August 27, 2014, to Supply Agreement, by and between LDR Médical, S.A.S and Invibio Ltd.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			LDR HOLDING CORPORATION
Dated:	August 27, 2014	By:	/s/ Scott Way
			Scott Way
			Executive Vice President, General Counsel, Compliance Officer and Secretary

EXHIBIT INDEX

Exhibit Number	Description
10.1	Amendment, dated August 27, 2014, to Supply Agreement, by and between LDR Médical, S.A.S and Invibio Ltd.